Reporte zur Charge 041L20A041L20A

Symptomtext

The redness it was the size of an apple; it was very itchy; swelling; been having frequent headches lately; left a black shadowy bruising; pain on the site; had fever; chills; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (pain on the site), PYREXIA (had fever), CHILLS (chills), ERYTHEMA (The redness it was the size of an apple) and PRURITUS (it was very itchy) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. Concomitant products included ASCORBIC ACID (VITAMIN C ACID) and BIOTIN for an unknown indication. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced VACCINATION SITE PAIN (pain on the site), PYREXIA (had fever) and CHILLS (chills). On an unknown date, the patient experienced ERYTHEMA (The redness it was the size of an apple), PRURITUS (it was very itchy), SWELLING (swelling), HEADACHE (been having frequent headches lately) and CONTUSION (left a black shadowy bruising). At the time of the report, VACCINATION SITE PAIN (pain on the site), PYREXIA (had fever), CHILLS (chills), ERYTHEMA (The redness it was the size of an apple), PRURITUS (it was very itchy), SWELLING (swelling) and HEADACHE (been having frequent headches lately) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were reported.